Identification of CALU and PALLD as Potential Biomarkers Associated With Immune Infiltration in Heart Failure

Xing Liu1, Shiyue Xu2, Ying Li3

  • 1Department of Cardiovascular Medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Insights

This study identifies CALU and PALLD as potential biomarkers for heart failure (HF) due to ischemic cardiomyopathy. Lower levels of these proteins in blood correlate with increased immune cell infiltration, suggesting their role in HF pathogenesis.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Biomarker Discovery

Background:

  • Inflammatory activation and immune cell infiltration are key in heart failure (HF) pathogenesis.
  • Ischemic cardiomyopathy (CM) is a major cause of HF, involving complex immune responses.

Purpose of the Study:

  • To investigate immune infiltration patterns in HF patients with ischemic cardiomyopathy.
  • To identify novel diagnostic biomarkers associated with immune infiltration in this patient group.

Main Methods:

  • Analysis of gene expression data from ischemic cardiomyopathy (CM) and non-heart failure (NF) samples.
  • Identification of differentially expressed genes (DEGs) and immune cell infiltration landscape using ssGSEA.
  • Weighted gene co-expression network analysis (WGCNA) to identify relevant gene modules.
  • Validation of candidate biomarkers (CALU, PALLD) in peripheral blood mononuclear cells (PBMCs).

Main Results:

  • 224 DEGs were identified, enriched in protein processing and extracellular matrix pathways.
  • Increased infiltration of dendritic cells, mast cells, NK cells, and various T cell subsets was observed in CM.
  • Calumenin (CALU) and palladin (PALLD) showed significant inverse correlation with pro-inflammatory immune cells and positive correlation with central memory T cells.
  • CALU and PALLD mRNA levels were significantly lower in PBMCs from CM patients.

Conclusions:

  • CALU and PALLD are significantly associated with altered immune cell infiltration in heart failure due to ischemic cardiomyopathy.
  • These proteins represent promising diagnostic biomarkers for immune-related HF.
  • Further research into the functional role of CALU and PALLD in HF is warranted.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
252
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
390
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
314